eCommons

 

Canine immune-mediated hemolytic anemia : presentation and treatment

dc.contributor.authorGood, Jennifer
dc.date.accessioned2006-04-06T14:53:07Z
dc.date.available2006-04-06T14:53:07Z
dc.date.issued2002-09-04
dc.descriptionSenior seminar (D.V.M.) -- Cornell University, 2003. Includes bibliographical references (leaves 11-12).en_US
dc.description.abstractCanine immune mediated hemolytic anemia (IMHA) is an autoimmune disease characterized by the increased destruction of red blood cells by autoantibodies. A type two hypersensitivity reaction, it can be primary or secondary in nature. Most cases are primary (idiopathic) but secondary IMHA can occur with concurrent infection, such as with the blood parasites (Ehrlichia and Babesia) or leptospirosis, with inflammation or immune mediated processes such as systemic lupus erythematosus or with lymphoid malignancies. Viral infection can also predispose an animal to IMHA, in particular parvovirus and distemper. Treatment of IMHA centers on finding the causative agent, in the case of secondary disease, and on immunosuppressive therapy with drugs such as corticosteroids, cyclosporine, azathioprine and cyclophosphamide. The short-term prognosis for dogs with IMHA is guarded due to the multiple complications inherent in the acute stages of the disease. If an animal survives acute disease the long term prognosis is fair. Dogs frequently experience relapse and may become refractory to previous therapies with each relapse. This study centers on the case of Scooter, an English bulldog, who was diagnosed at Cornell University's Hospital for Animals with IMHA in June of 2002. en_US
dc.description.sponsorshipAdvisor: Dr. Tristan Weinkle / Clinicians: Dr. Richard Goldstein, Dr. Stephen Barr, Dr. Tristan Weinkleen_US
dc.format.extent68375 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/1813/2746
dc.language.isoen_US
dc.relation.ispartofseriesSenior seminar paper
dc.relation.ispartofseriesSeminar SF610.1 2003 G66
dc.subjectDogs -- Diseases -- Treatment -- Case studiesen_US
dc.titleCanine immune-mediated hemolytic anemia : presentation and treatmenten_US
dc.typeterm paperen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2003 Good.pdf
Size:
66.77 KB
Format:
Adobe Portable Document Format